No human testing yet, but scientists say they've identified, and figured out how to fight, proteins that prompt brain cells to go rogue and lead to secondary growths
Medicine fell foul of regulators despite helping patients, as it required large dose. Now, Technion's pinpoint delivery system cuts quantity needed, allowing revival of drug
Joint research aims to find microbiome-based drugs that will enhance patient response and reduce adverse effects of immunotherapies in melanoma patients
Three melanoma patients with weeks to live responded to treatment after taking capsules of poop that transformed gut microbiome, Sheba-based team reports in peer-reviewed research
Immunotherapy needs peptides to work, but if a patient has too few, anti-cancer drugs will fall short; discovery of new type by Weizmann Institute-led team could solve problem
Melanoma cells activate and make use of inflammatory pathway to brain, Tel Aviv University team says; in mice study, the scientists managed to 'significantly' inhibit migration
Recent comments